Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DRK
12851
PUT
DarkHorse Technologies Inc. Common Shares
DRK
$29.9M
| $16.6K | ﹤0.01% |
1,830
-2,900
| -61% | -$27.6K |
2021 Q3
12 quarters
|
|
|
OCFT
12852
CALL
DELISTED
OneConnect Financial Technology
OCFT
| $16.5K | ﹤0.01% |
5,900
+800
| +16% | +$1.2K |
2024 Q2
1 quarter
|
|
12853
Focus Universal
FCUV
$3.04M
| $16.5K | ﹤0.01% |
+156
| New | +$16.6K |
2024 Q3
0 quarters
|
|
12854
CALL
OneSpaWorld
OSW
$2.36B
| $16.5K | ﹤0.01% |
1,000
-10,400
| -91% | -$165K |
2022 Q3
8 quarters
|
|
|
INST
12855
PUT
DELISTED
Instructure Holdings, Inc.
INST
| $16.5K | ﹤0.01% |
700
-400
| -36% | -$9.44K |
2023 Q1
6 quarters
|
|
12856
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$83.4M
| $16.5K | ﹤0.01% |
+899
| New | +$11.6K |
2024 Q3
0 quarters
|
|
12857
CALL
Protara Therapeutics
TARA
$151M
| $16.5K | ﹤0.01% |
9,000
+600
| +7% | +$1.23K |
2023 Q4
3 quarters
|
|
12858
SLR Investment Corp
SLRC
$628M
| $16.4K | ﹤0.01% |
1,087
-84,333
| -99% | -$1.31M |
2023 Q2
5 quarters
|
|
12859
PUT
Safety Insurance
SAFT
$1.52B
| $16.4K | ﹤0.01% |
200
+100
| +100% | +$8.22K |
2022 Q4
7 quarters
|
|
12860
AmpliTech
AMPG
$90.1M
| $16.3K | ﹤0.01% |
20,836
-77,146
| -79% | -$73.9K |
2023 Q1
6 quarters
|
|
|
SBDS
12861
DELISTED
Solo Brands Inc
SBDS
| $16.2K | ﹤0.01% |
288
-929
| -76% | -$66.1K |
2022 Q4
7 quarters
|
|
12862
PUT
Evolus
EOLS
$494M
| $16.2K | ﹤0.01% |
1,000
-12,700
| -93% | -$178K |
2022 Q4
7 quarters
|
|
12863
PUT
KRONOS Worldwide
KRO
$917M
| $16.2K | ﹤0.01% |
1,300
+1,000
| +333% | +$11.6K |
2022 Q4
7 quarters
|
|
|
NSLR
12864
PUT
Neostellar Capital Corp
NSLR
$200M
| $16.1K | ﹤0.01% |
+4,000
| New | +$15.7K |
2024 Q3
0 quarters
|
|
12865
CALL
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.74B
| $16.1K | ﹤0.01% |
300
+100
| +50% | +$5.21K |
2022 Q4
7 quarters
|
|
12866
PUT
RLX Technology
RLX
$2.1B
| $16.1K | ﹤0.01% |
8,900
-1,000
| -10% | -$1.72K |
2021 Q1
14 quarters
|
|
12867
GSI Technology
GSIT
$217M
| $16.1K | ﹤0.01% |
+5,276
| New | +$14.4K |
2024 Q3
0 quarters
|
|
12868
CALL
Zevia
ZVIA
$88M
| $16.1K | ﹤0.01% |
14,900
-55,200
| -79% | -$52.2K |
2023 Q4
3 quarters
|
|
|
STAF
12869
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
| $16.1K | ﹤0.01% |
+11,576
| New | +$22K |
2024 Q3
0 quarters
|
|
12870
PUT
Citius Pharmaceuticals
CTXR
$13.8M
| $16.1K | ﹤0.01% |
+1,284
| New | +$21.6K |
2024 Q3
0 quarters
|
|
12871
CALL
Preferred Bank
PFBC
$1.24B
| $16.1K | ﹤0.01% |
+200
| New | +$16K |
2024 Q3
0 quarters
|
|
12872
Marchex
MCHX
$59.9M
| $15.9K | ﹤0.01% |
8,507
-38,826
| -82% | -$68.2K |
2022 Q4
7 quarters
|
|
12873
Maison Solutions
MSS
$1.49M
| $15.9K | ﹤0.01% |
+215
| New | +$10.7K |
2024 Q3
0 quarters
|
|
12874
CALL
KraneShares Global Carbon Strategy ETF
KRBN
$136M
| $15.8K | ﹤0.01% |
+500
| New | +$16.2K |
2024 Q3
0 quarters
|
|
12875
Silo Pharma
SILO
$2.96M
| $15.8K | ﹤0.01% |
+958
| New | +$20.4K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.